文献速递免疫规划慢病防控与筛查

2型糖尿病损害ChAdOx1 nCoV-19疫苗接种后的SARS-CoV-2特异性免疫记忆

Type 2 diabetes compromises SARS-CoV-2-specific immunological memory following ChAdOx1 nCoV-19 vaccination.
PubMed 文献 · Vaccine · 2025-08-12

研究纳入55例2型糖尿病(T2D)和60例健康对照(HC),在ChAdOx1 nCoV-19疫苗接种后第3、6、12个月监测免疫指标。结果发现T2D组COVID-19发病率显著更高、SARS-CoV-2特异性CD8+ T细胞频率更低、回忆反应减弱、记忆B细胞频率降低,提示T2D个体疫苗诱导的SARS-CoV-2特异性免疫记忆受损。

要点

  • T2D组接种后COVID-19发病率显著高于HC组,提示突破感染率增加。
  • T2D组SARS-CoV-2特异性外周CD8+ T细胞频率更低,体外淋巴细胞增殖减少。
  • T2D组记忆B细胞频率降低,提示疫苗诱导的免疫记忆受损。

核心结论

  • 数据表明,与健康对照相比,2型糖尿病个体表现出疫苗诱导的SARS-CoV-2特异性免疫记忆受损。
  • 健康对照则表现出促炎与抗炎反应之间良好调节的平衡。

研究设计与样本

  • 研究招募55例2型糖尿病(T2D)和60例健康对照(HC)受试者。
  • 在ChAdOx1 nCoV-19疫苗接种后基线、第3、6、12个月监测免疫学参数。
  • 采用MHC-I dextramer检测SARS-CoV-2表位特异性CD8+ T细胞频率,以SARS-CoV-2 S蛋白肽池(SP)体外刺激评估淋巴细胞增殖、胞内(TNF-α、IFN-γ)和胞外(IL-2、IL-4、IL-6、IL-10、IFN-γ、TGF-β)细胞因子,并检测抗S抗体滴度及记忆B细胞(CD19+ CD27+)、浆母细胞(CD19+ CD27hiCD38hi)和浆细胞(CD38hi CD138+)频率。

主要发现

  • 接种后T2D组COVID-19发病率显著高于HC组,提示突破感染率增加。
  • T2D组SARS-CoV-2特异性外周CD8+ T细胞频率低于HC组,体外淋巴细胞增殖减少提示回忆反应减弱。
  • 突破性COVID-19期间,T2D组全身IFN-γ水平升高,而较高IL-10水平仅在HC组观察到。
  • SP刺激后,HC组中更高比例的CD8+和CD4+ T细胞表达IFN-γ和TNF-α,表明抗病毒细胞介导免疫反应更强。
  • B细胞免疫表型分析显示T2D组记忆B细胞频率降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Despite the success of vaccination, isolated cases of COVID-19 infection are being reported in the vulnerable subjects worldwide. Given that individuals with type-2 diabetes (T2D) often exhibit immune dysregulation, this study aimed to characterize SARS-CoV-2-specific immunity following ChAdOx1 nCoV-19 vaccination in subjects with T2D. METHODS: We recruited 55 T2D and 60 healthy control (HC) subjects and monitored their immunological parameters at baseline, 3rd, 6th, and 12th month post-ChAdOx1 nCoV-19 vaccination. The frequency of SARS-CoV-2 epitope-specific CD8+ T cells were determined using MHC-I dextramers. The SARS-CoV-2 specific recall responses were assessed by lymphocyte proliferation, intracellular (TNF-α, IFN-γ) and extracellular (IL-2, IL-4, IL-6, IL-10, IFN-γ, TGF-β) cytokine estimation following in-vitro stimulation with SARS-CoV-2 S-protein peptide pool (SP). The anti-S antibody titers and the frequency of memory B cells (CD19+ CD27+), plasmablasts (CD19+ CD27hiCD38hi), and plasma cells (CD38hi CD138+) were also determined. RESULTS: Following vaccination, the incidence of COVID-19 disease was significantly higher in T2D individuals, suggesting an increased rate of breakthrough infections. The T2D cohort also exhibited lower frequency of SARS-CoV-2-specific peripheral CD8+ T cells and demonstrated diminished recall responses, as evidenced by reduced in-vitro lymphocyte proliferation. During breakthrough COVID-19 disease, systemic levels of IFN-γ were elevated in T2D subjects, whereas higher IL-10 levels were observed only in HC. Upon SP stimulation, a greater proportion of CD8+ and CD4+ T cells from HC expressed IFN-γ and TNF-α, indicating a more robust antiviral cell-mediated immune response. Additionally, B cell immunophenotyping revealed a reduced frequency of memory B cells in T2D. CONCLUSION: The data indicate that individuals with T2D exhibit impaired vaccine-induced SARS-CoV-2-specific immunological memory, in contrast to HC, who demonstrate a well-regulated balance between pro- and anti-inflammatory responses.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Bhat S, Basak P, Verma S, et al. Type 2 diabetes compromises SARS-CoV-2-specific immunological memory following ChAdOx1 nCoV-19 vaccination. Vaccine. 2025. PMID: 40803144. doi:10.1016/j.vaccine.2025.127604

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。